Stock listing

PBLS Stock Price, News, Filings & Events — Parabilis Medicines, Inc.

Selected listing: PBLS · BOATS · USD · US

This page tracks Parabilis Medicines, Inc.'s PBLS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBLS:BOATS. PBLS:BOATS is the stock-level entry point for investors researching Parabilis Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Parabilis Medicines, Inc. is a public company traded under the ticker PBLS in the American market. With a market capitalization of approximately $3.49 billion, the company is focused on advancing its innovative therapies. Parabilis is dedicated to improving patient outcomes through its research and development efforts in the biopharmaceutical sector.

PBLS:BOATSUSDUSUpdated August 22, 2026
Ticker
PBLS:BOATS
Asset type
Stock
Market cap
$4.86B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Parabilis Medicines, Inc. PBLS:BOATS stock context

This page tracks Parabilis Medicines, Inc.'s PBLS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBLS:BOATS. PBLS:BOATS is the stock-level entry point for investors researching Parabilis Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Parabilis Medicines, Inc. is a public company traded under the ticker PBLS in the American market. With a market capitalization of approximately $3.49 billion, the company is focused on advancing its innovative therapies. Parabilis is dedicated to improving patient outcomes through its research and development efforts in the biopharmaceutical sector.

Latest news from Parabilis Medicines, Inc.

All Parabilis Medicines, Inc. news →

Research Parabilis Medicines, Inc.

Alternate listings